These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25387598)

  • 21. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a pregabalin step therapy policy among medicare advantage beneficiaries.
    Suehs BT; Louder A; Udall M; Cappelleri JC; Joshi AV; Patel NC
    Pain Pract; 2014 Jun; 14(5):419-26. PubMed ID: 23701733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
    Gore M; Sadosky AB; Zlateva G; Clauw DJ
    Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
    Udall M; Harnett J; Mardekian J
    J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia.
    Gore M; Sadosky A; Zlateva G; Clauw D
    Am J Manag Care; 2010 May; 16(5 Suppl):S144-53. PubMed ID: 20586523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Financial and clinical characteristics of fibromyalgia: a case-control comparison.
    Palacio A; Uribe CL; Li H; Hanna J; Deminski M; Alvir J; Chandran A; Sanchez R
    Am J Manag Care; 2010 May; 16(5 Suppl):S118-25. PubMed ID: 20586520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs.
    Martin C; Odell K; Cappelleri JC; Bancroft T; Halpern R; Sadosky A
    J Manag Care Spec Pharm; 2016 Feb; 22(2):132-44. PubMed ID: 27015252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
    Bellows BK; Nelson RE; Oderda GM; LaFleur J
    Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia.
    Berger A; Sadosky A; Dukes EM; Edelsberg J; Zlateva G; Oster G
    Am J Manag Care; 2010 May; 16(5 Suppl):S126-37. PubMed ID: 20586521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Impact of Adherence to Pain Treatment Guidelines in Chronic Pain Patients.
    Margolis JM; Princic N; Smith DM; Abraham L; Cappelleri JC; Shah SN; Park PW
    Pain Med; 2019 Oct; 20(10):1907-1918. PubMed ID: 31034040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of fibromyalgia.
    Mease PJ; Dundon K; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):285-97. PubMed ID: 22094202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Am J Health Syst Pharm; 2013 Dec; 70(24):2207-17. PubMed ID: 24296843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
    Kim SC; Landon JE; Lee YC
    Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
    Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
    Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current progress in the pharmacological therapy of fibromyalgia.
    Rao SG
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
    Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of pain medication selection among patients diagnosed with fibromyalgia.
    Boulanger L; Wu N; Chen SY; Nagar S; Fraser K; Bernauer MJ; Zhao Z; Zhao Y
    Pain Pract; 2012 Apr; 12(4):266-75. PubMed ID: 21899718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.